ATE344325T1 - Neisseria lactoferrin-bindendes protein - Google Patents

Neisseria lactoferrin-bindendes protein

Info

Publication number
ATE344325T1
ATE344325T1 AT98945224T AT98945224T ATE344325T1 AT E344325 T1 ATE344325 T1 AT E344325T1 AT 98945224 T AT98945224 T AT 98945224T AT 98945224 T AT98945224 T AT 98945224T AT E344325 T1 ATE344325 T1 AT E344325T1
Authority
AT
Austria
Prior art keywords
lactoferrin
neisseria
binding protein
polypeptides
polynucleotides
Prior art date
Application number
AT98945224T
Other languages
English (en)
Inventor
Annika Mar Pettersson-Fernholm
Johannes Petrus Mari Tommassen
Original Assignee
Univ Utrecht
Stw Technology Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9717423.9A external-priority patent/GB9717423D0/en
Priority claimed from GBGB9802544.8A external-priority patent/GB9802544D0/en
Application filed by Univ Utrecht, Stw Technology Foundation filed Critical Univ Utrecht
Application granted granted Critical
Publication of ATE344325T1 publication Critical patent/ATE344325T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT98945224T 1997-08-15 1998-08-10 Neisseria lactoferrin-bindendes protein ATE344325T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9717423.9A GB9717423D0 (en) 1997-08-15 1997-08-15 Vaccine
GBGB9802544.8A GB9802544D0 (en) 1998-02-05 1998-02-05 Vaccine

Publications (1)

Publication Number Publication Date
ATE344325T1 true ATE344325T1 (de) 2006-11-15

Family

ID=26312080

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98945224T ATE344325T1 (de) 1997-08-15 1998-08-10 Neisseria lactoferrin-bindendes protein

Country Status (18)

Country Link
US (1) US7105316B2 (de)
EP (1) EP1003874B1 (de)
JP (1) JP2001514894A (de)
KR (1) KR100509712B1 (de)
CN (1) CN1204253C (de)
AT (1) ATE344325T1 (de)
AU (1) AU744733B2 (de)
BR (1) BR9811907A (de)
CA (1) CA2301332A1 (de)
CO (1) CO4810233A1 (de)
DE (1) DE69836333T2 (de)
ES (1) ES2275314T3 (de)
IL (1) IL134436A0 (de)
NO (1) NO20000731L (de)
NZ (1) NZ502750A (de)
PL (1) PL194800B1 (de)
TR (1) TR200000416T2 (de)
WO (1) WO1999009176A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0010721A (pt) * 1999-05-19 2002-06-11 Chiron Spa Composições de neisserias combinadas
GB0007433D0 (en) * 2000-03-27 2000-05-17 Microbiological Res Authority Recombinant transferrin binding proteins
GB0011108D0 (en) * 2000-05-08 2000-06-28 Microscience Ltd Virulence gene and protein and their use
GB0107219D0 (en) * 2001-03-22 2001-05-16 Microbiological Res Authority Immunogenic commensal neisseria sequences
DE20321889U1 (de) 2002-08-02 2012-03-12 Glaxosmithkline Biologicals S.A. Impfstoffzusammensetzung
ATE474595T1 (de) 2003-10-02 2010-08-15 Glaxosmithkline Biolog Sa B. pertussis antigene und ihre verwendung bei der vakzinierung
GB0409748D0 (en) * 2004-04-30 2004-06-09 Chiron Srl Lactoferrin cleavage
EP2032161B1 (de) 2006-06-12 2012-07-11 GlaxoSmithKline Biologicals S.A. L3v los impfstoffe
JP2013521326A (ja) 2010-03-10 2013-06-10 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
JP7832653B2 (ja) * 2022-02-08 2026-03-18 国立大学法人京都工芸繊維大学 ラクトフェリン、コンカナバリンａ、リゾチーム及び／またはヘモグロビンを介して抗体等が固定されたニトロセルロース膜の製造方法及び抗原結合性等の増強方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
US6048539A (en) 1995-11-02 2000-04-11 Connaught Laboratories Limited Lactoferrin receptor protein

Also Published As

Publication number Publication date
EP1003874B1 (de) 2006-11-02
KR20010022952A (ko) 2001-03-26
JP2001514894A (ja) 2001-09-18
CO4810233A1 (es) 1999-06-30
PL338649A1 (en) 2000-11-06
CN1204253C (zh) 2005-06-01
CN1275164A (zh) 2000-11-29
DE69836333D1 (de) 2006-12-14
AU9261398A (en) 1999-03-08
PL194800B1 (pl) 2007-07-31
US7105316B2 (en) 2006-09-12
EP1003874A1 (de) 2000-05-31
NZ502750A (en) 2002-03-01
WO1999009176A1 (en) 1999-02-25
US20040131634A1 (en) 2004-07-08
TR200000416T2 (tr) 2000-07-21
NO20000731D0 (no) 2000-02-14
IL134436A0 (en) 2001-04-30
NO20000731L (no) 2000-03-31
ES2275314T3 (es) 2007-06-01
DE69836333T2 (de) 2007-04-19
CA2301332A1 (en) 1999-02-25
AU744733B2 (en) 2002-02-28
BR9811907A (pt) 2000-08-15
KR100509712B1 (ko) 2005-08-24

Similar Documents

Publication Publication Date Title
ATE180261T1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
WO1998031799A3 (en) Polynucleotides and polypeptides encoding receptors
FR2661187B1 (fr) Proteine associee a la pancreatite aiguue. moyens pour le diagnostic de la pancreatite aiguue.
EP0848062A3 (de) Aspartylprotease ASP1
DE69935220D1 (de) Von menschlichem tumor stammendes polypeptidhormon phosphatonin
BR9910396A (pt) Polinucleotìdeo(s) e polipeptìdeos basb029 a partirde neisseria meningitidis
DE69836333D1 (de) Neisseria lactoferrin-bindendes protein
EP0939124A3 (de) MBGP1-Sequenzen
WO2000015659A3 (en) Stomach polypeptide zsig28
WO1999035266A3 (en) Human urotensin ii
EP0885959A3 (de) Menschlisches Wnt-5b Protein
DE69918446D1 (de) Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen
EP0943684A3 (de) Frizzled-ähnliche Polypeptide und Polynukleotide
EP0879888A3 (de) Patched-2 Polypeptide und Polynucleotide und Methoden zu ihrer Herstellung
NO992531L (no) Fremgangsmåter ved fremstilling av rekombinant protein
DE60117788D1 (de) Menschliche wingless-änhliche gene
DK1122307T3 (da) Human carnosinase 2
EP0887416A3 (de) Menschliches AFC1 Enzym
ATE281524T1 (de) Moraxella catarrhalis pilq proteine
NZ514691A (en) Method to type prion proteins
EP0875577A3 (de) Gen der Membrantyp-Matrix-Metalloproteinase-5
WO1999038885A3 (en) Sbsemvl polypeptides, being members of the semaphorin protein family, and polynucleotides encoding the same
WO2001068816A8 (en) Human histamine h3 gene variant-3
EP0897009A3 (de) HKABY60 Polypeptide
NO20016340L (no) Hodetraumeindusert cytoplasmatisk kalsiumbindende protein

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties